MediciNova Inc (MNOV)-Financial and Strategic SWOT Analysis Review

MediciNova Inc (MNOV)-Financial and Strategic SWOT Analysis Review

  • Products Id :- GDPH61527FSA
  • |
  • Pages: 38
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

MediciNova Inc (MNOV)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


MediciNova Inc (MediciNova) is a biopharmaceutical company, which focuses on acquiring, and developing novel, small-molecule therapeutics for the treatment of neurology, respiratory, and liver diseases. MediciNova's developmental pipeline includes core programs such as MN-001, for the treatment of nonalcoholic steatohepatitis; MN-166, for neurological disorders; and MN-221, for respiratory diseases. The company's non-core programs include MN-001 being developed for two indications, namely, bronchial asthma and interstitial cystitis; MN-029 for the treatment of solid tumors; and MN-221 for the treatment of preterm labor. It has partnerships with various companies such as Kissei Pharmaceutical Co., Ltd., Kyorin Pharmaceutical Co., Ltd., Angiogene Pharmaceuticals Ltd and Meiji Seika Kaisha Ltd., to develop and commercialize its products. MediciNova is headquartered in California, the US.

MediciNova Inc Key Recent Developments

Dec 14,2016: MediciNova Added to NASDAQ Biotechnology Index

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

MediciNova Inc-Key Facts 5

MediciNova Inc-Key Employees 6

MediciNova Inc-Key Employee Biographies 7

MediciNova Inc-Major Products and Services 8

MediciNova Inc-Pharmaceutical Pipeline Products Data 9

MediciNova Inc, Pipeline Products by Therapy Area 9

MediciNova Inc, Pipeline Products by Development Phase 10

MediciNova Inc-History 11

MediciNova Inc-Company Statement 14

MediciNova Inc-Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Section 2-Company Analysis 17

MediciNova Inc-Business Description 17

MediciNova Inc-Corporate Strategy 18

MediciNova Inc-SWOT Analysis 19

SWOT Analysis-Overview 19

MediciNova Inc-Strengths 19

MediciNova Inc-Weaknesses 20

MediciNova Inc-Opportunities 21

MediciNova Inc-Threats 22

MediciNova Inc-Key Competitors 23

Section 3-Company Financial Ratios 24

Financial Ratios-Capital Market Ratios 24

Financial Ratios-Annual Ratios 25

Performance Chart 27

Financial Performance 27

Financial Ratios-Interim Ratios 28

Financial Ratios-Ratio Charts 29

Section 4-Company's Lifesciences Financial Deals and Alliances 30

MediciNova Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 30

MediciNova Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 31

MediciNova Inc, Recent Deals Summary 32

Section 5-Company's Recent Developments 33

Dec 14, 2016: MediciNova Added to NASDAQ Biotechnology Index 33

Section 6-Appendix 34

Methodology 34

Ratio Definitions 34

About GlobalData 38

Contact Us 38

Disclaimer 38

List of Figures

MediciNova Inc, Pipeline Products by Therapy Area 9

MediciNova Inc, Pipeline Products by Development Phase 10

MediciNova Inc, Performance Chart (2012-2016) 27

MediciNova Inc, Ratio Charts 29

MediciNova Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 30

MediciNova Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 31

List of Tables

MediciNova Inc, Key Facts 5

MediciNova Inc, Key Employees 6

MediciNova Inc, Key Employee Biographies 7

MediciNova Inc, Major Products and Services 8

MediciNova Inc, Number of Pipeline Products by Therapy Area 9

MediciNova Inc, Number of Pipeline Products by Development Stage 10

MediciNova Inc, History 11

MediciNova Inc, Subsidiaries 16

MediciNova Inc, Key Competitors 23

MediciNova Inc, Ratios based on current share price 24

MediciNova Inc, Annual Ratios 25

MediciNova Inc, Annual Ratios (Cont...1) 26

MediciNova Inc, Interim Ratios 28

MediciNova Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 30

MediciNova Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 31

MediciNova Inc, Recent Deals Summary 32

Currency Codes 34

Capital Market Ratios 34

Equity Ratios 35

Profitability Ratios 35

Cost Ratios 36

Liquidity Ratios 36

Leverage Ratios 37

Efficiency Ratios 37

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@]

select a license

Single User License
USD 125 INR 8089
Site License
USD 250 INR 16178
Corporate User License
USD 375 INR 24266



The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...

Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

query [@]